Fig. 3.
Time course of plasma FVIII, VWF:Ag, and VWR:RCo levels observed before and at different times after subcutaneous DDAVP.
Subcutaneous DDAVP (0.4 μg/kg) in patient I-1 (▵—▵) compared with that in healthy subject (○—○). Similar results were observed in the other patients and healthy subjects studied.